Language selection

Search

Patent 1208548 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1208548
(21) Application Number: 1208548
(54) English Title: METHOD FOR THE DETERMINATION OF ANTIGENS
(54) French Title: METHODE DE DETERMINATION DE LA TENEUR EN ANTIGENES
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • G1N 33/542 (2006.01)
  • G1N 33/557 (2006.01)
(72) Inventors :
  • DANNINGER, JOSEF (Germany)
  • SPATHE, REINER (Germany)
(73) Owners :
  • DADE BEHRING INC.
(71) Applicants :
  • DADE BEHRING INC. (United States of America)
(74) Agent: KIRBY EADES GALE BAKER
(74) Associate agent:
(45) Issued: 1986-07-29
(22) Filed Date: 1983-03-31
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 32 12 658.1 (Germany) 1982-04-05

Abstracts

English Abstract


- 1 -
Abstract
In the photometric determination of the antigen content by
the antigen-antibody-reaction at least one of the two
reaction components is diluted with a physiological salt
solution, which contains, beside polyethylenglycol a buffer
substance, before the two reaction components are combined.


Claims

Note: Claims are shown in the official language in which they were submitted.


Claims:
1. A method for the determination of the antigen content
of a sample by an antigen-antibody reaction involving the
mixing of a reaction component containing the antigen and
a reaction component containing an antibody, comprising
first diluting at least one of the two reaction compon-
ents with a physiological saline solution which contains
polyethyleneglycol and a buffer substance, thereafter
combining both reaction components and determining the
antigen-antibody reaction photometeically in the presence
of a buffer substance, wherein the buffer substance is
selected from the group consisting of a glycin, glycyl-
glycin, acetate, citrate, bicine, histidin/HCl, tris or
5.5-dialkylbarbituric acid buffer.
2. A method according to claim 1, wherein the 5.5-dialkyl-
barbituric acid is 5.5-diethylbarbituric acid.
3. A method according to claim 1 wherein the concentration
of buffer substance in the salt solution is 5 to 200 mmol/l.
4. A method according to any one of claims 1 to 3, wherein
the concentration of the polyethyleneglycol in the salt
solution is 2 to 6% by weight, and the average molecular
weight of the polyethyleneglycol is 4000 to 12000.
5. A method according to any one of claims 1 to 3, wherein
the pH-value of the physiological salt solution containing
the buffer substance and the polyethylenelgycol is 4,0 to 9,0.
6. A method according to any one of claims 1 to 3,
wherein the photometrical determination of the kinetic
progression of the antigen-antibody-reaction is performed.
7. A polyethylene containing, physiological salt solution
which can be used as a diluent of at least one of two
reaction components of an antigen-antibody-reaction for
the photometrical determination of the antigen content,
wherein said solution contains a buffer substance selected
from the group consisting of a glycin, glycylglycin,
acetate, citrate, bicine, histidin/HCl, tris or 5.5-
dialkylbarbituric acid buffer.

Description

Note: Descriptions are shown in the official language in which they were submitted.


- ~Z08548
-- 1 --
The invention relates to a method for the determination
of the antigen content in a sample by the antigen-antibody-
reaction. It also relates to a diluent for an antigen
and antibody component, respectively, for preforming this
method.
The determination of diagnostic relevant parameters with
antigens in samples, as serum, plasma or liquor, by the
immunological or antigen-antibody-reaction, which is
evaluated photometrically for instance by nephelometry
or turbidimetry, makes frequently a special preparation
of both reaction components necessary. Usually the re-
action component which contains the sample which antigen
content has to be determined, and the other component
which contains the antibody, i.e. which is normally the
corresponding antiserum, are diluted with physiological
salt solution or with physiological salt solution which
contains in addition 4~ polyethylenglycol (average
molecular weight 6000).
The content of polyethylenglycol serves particularly to
avoid a precipitation of the antigen-antibody-complexes
formed during the reaction, i.e. to avoid the formation
of a precipitation in the test solution formed by the com-
bination of both reaction components during the antigen
determination, i.e. during the measurement. This property
of polyethylenglycol is known for a certain period of
time and is a necessity for these measurements, because
otherwlse not all formed antigen-antibody-comple~es are
subjected to the measurement.
l'he determination of immune globulins by laser turbidimetry
according to the "Arbeitsanleitung fur das Lasermed-
Turbidometer (pm 4) zur Bestimmung der Immunglobuline IgA,
IgG, IgM mit ATAB-Antiseren (Instructions for the Lasermed-
turbidometer (pm 4) for determining the immune globulins
'~

208S~8
-- 2 --
IgA, IgG, IgM with ATAB-anitsera), AHS Deutschland GmbH,
Bereich ~lerz und Dade, Munich, 1982", showed that with
different physiological salt solutions with 4% by weight
polyethylenglycol different measurement signals were
obtained with the laser turbidometer during the assay,
although they (the salt solutions) were prepared according
to the same formulation and with the same reagents by the
same person. Accordingly no sufficiently reproducible
results were obtained. The so called kinetic method
shows a particular interference when according to said
instructions after a prereaction of 10 sec. the rate of
the antigen-antibody-reaction is measured and the antigen
content is determined. In contrast to the so called "Fix
point"-method according to said instructions, i.e. the
final poin~ measurement after a reaction period of for
instance 30 min, it is not necessary with said kinetic
method to wait until the end of the completion of the
antigen-antibody-reaction.
According to one aspect of the invention there is provided
a method for the determination of the antigen content of
a sample by an antigen-antibody reaction involving the
mixing of a reaction component containing the antigen and
a reaction component containing an antibody, comprising
first diluting at least one of the two reaction compon-
ents with a physiological saline solution which containspolyethyleneglycol and a buffer substance, thereafter
combining both reaction components and determining the
antigen-antibody reaction photometrically in the pre.sence
of a buffer sub~tance, wherein the buffer substance is
selected from the group consisting of a glycin, glycyl-
glycin, acetate, citrate, bicine, histidin/HCl, tcis or
5.5-dialkylbarbituric acid buffer~
According to another aspect of the invention there is
provided a polyethylene containing, physiological salt

` ~2~)85~18
- 2a -
solution which can be used as a diluent of at least one
of two reaction components of an antigen-antibody-reaction
for the photometrical determination of the antigen content,
wherein said solution contains a buffer substance selected
from the group consisting of a glycin, glycylglycin,
acetate, citrate, bicine, histidin/HCl, tris or 5.5-
dialkylbarbituric acid buffer.
The invention solves the object to provide a method and a
diluent, respectively, with which the antigen content of
sample is exactly and reproducibly determinable even with
the kinetic method.
The antibody molecule has a polyvalent and therefore a
strongly structured form whereas the polyethyleneglycol
is non-polar and therefore not structured. When koth
reaction components are combined a fairly homogenous
partition, which gives fairly reproducible results, is
obtained not before a certain period has lapsed. The
method according to the invetion is based on the fact
that a fast and homogenous partition of both reaction
components is obtained by adding a buffer substance to
the polyethyleneglycol containing, physiological salt
solution, which eliminates the structured form of the
antibody molecule by balancing the charges.
~5

- ~20B54B
It is surprising that theirate of the antigen-antibody-
reaction is particularly dependent on the chemical composition
of the buffer substance, even far more than the concentration
of the buffer substance or the pH-value~ Also important is
in connection with the invention that not such buffer
substances are selected which provide the fastest reaction
rate, but such buffer substances are prefered, with which
a constant reaction rate in the beginning is obtained which
_ lasts for a certain period of time. This property of the
buffer substances used according to the invention stra1ghtens
the reaction to a certain degree, so that a linear progress
over a relatively long period is obtained. This improves the
accuracy of the results of the kinetic method considerably.
If for instance 20 mmol/l 5.5-diethylbarbituric acid, pH 7,5,
are added as buffer to the physlological salt solution
containing 4 % by weight polyethylenglycol a pre reaction
time of for instance 10 sec is followed by a measurement
time of for instance 30 sec. The period of 30 sec is a
measurement basis for the antigen determination which is
sufficient even for very accurate results.

Representative Drawing

Sorry, the representative drawing for patent document number 1208548 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Inactive: Expired (old Act Patent) latest possible expiry date 2003-07-29
Letter Sent 1999-12-10
Inactive: Multiple transfers 1999-08-23
Grant by Issuance 1986-07-29

Abandonment History

There is no abandonment history.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Registration of a document 1999-08-23
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
DADE BEHRING INC.
Past Owners on Record
JOSEF DANNINGER
REINER SPATHE
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

({010=All Documents, 020=As Filed, 030=As Open to Public Inspection, 040=At Issuance, 050=Examination, 060=Incoming Correspondence, 070=Miscellaneous, 080=Outgoing Correspondence, 090=Payment})


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1993-07-05 1 9
Claims 1993-07-05 1 42
Drawings 1993-07-05 1 6
Descriptions 1993-07-05 4 134